title: G84E mutation in HOXB13 is firmly associated with prostate cancer risk: a meta-analysis.
abstract: The rare but recurrent germline G84E mutation in HOXB13 was recently found to be associated with a significantly increased risk of familial prostate cancer (PCa). However, epidemiologic findings have been inconsistent. In an attempt to confirm and expand the findings that the PCa risk increased in men carrying G84E, we therefore performed a meta-analysis to clarify the association between the germline G84E mutation and PCa risk. We also aim to verify the increased PCa risk with respect to diagnostic age, family history, and disease aggressiveness. Comprehensive search of databases was carried out, and other relevant articles were also identified. Then, the meta-analyses were conducted according to the standard guidelines. A total of 11 studies with 120,167 participants were included on the basis of inclusion criteria. The G84E allele carrier frequencies ranged from 0.1 to 4.9 % in the patients with PCa, as compared with 0 to 1.4 % in control subjects. Men with the HOXB13 G84E variant had a 4.51-fold higher relative risk of PCa compared with non-carriers (95 % CI 3.28-6.20). The much higher risks were observed in individuals with early onset (odds ratio (OR) = 9.73, 95 % confidence interval (CI) 6.57-14.39), more than two affected relatives (OR = 7.27, 95 % CI 4.02-13.15), and highly aggressive disease (OR = 5.81, 95 % CI 3.72-9.08). Our findings provide further evidences that the rare mutation in HOXB13 contributes to both hereditary and sporadic PCa risk. Despite the low G84E carrier rate, biological and clinical implications of the mutation in subjects with early onset, more than two affected relatives, and highly aggressive disease remain important in continued investigation.
authors.affiliation: Department of Urology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 32500, China.
authors.forename: Hang
authors.initials: H
authors.lastname: Huang
authors.forename: Bing
authors.initials: B
authors.lastname: Cai
mesh_terms: D005787:Gene Frequency; D056726:Genetic Association Studies; D020022:Genetic Predisposition to Disease; D005838:Genotype; D018398:Homeodomain Proteins / Q000235:genetics*; D006801:Humans; D008297:Male; D009154:Mutation; D020641:Polymorphism, Single Nucleotide; D011471:Prostatic Neoplasms / Q000235:genetics* / Q000473:pathology; D012307:Risk Factors
chemical_list: C484414:HOXB13 protein, human; D018398:Homeodomain Proteins
references.citation: Nature. 1997 Nov 6;390(6655):29
references.pmid: 9363887
references.citation: Cancer Epidemiol Biomarkers Prev. 2013 Mar;22(3):452-60
references.pmid: 23292082
references.citation: PLoS Med. 2009 Jul 21;6(7):e1000097
references.pmid: 19621072
references.citation: Arch Phys Med Rehabil. 2006 Jun;87(6):875
references.pmid: 16731227
references.citation: Prostate. 2013 Jan;73(2):169-75
references.pmid: 22718278
references.citation: Dev Dyn. 1997 Apr;208(4):454-65
references.pmid: 9097018
references.citation: Nat Genet. 2011 Jul 10;43(8):785-91
references.pmid: 21743467
references.citation: Prostate. 2013 May;73(6):634-41
references.pmid: 23129385
references.citation: Cancer Epidemiol Biomarkers Prev. 2012 Aug;21(8):1348-53
references.pmid: 22714738
references.citation: Hum Genet. 2013 Jan;132(1):5-14
references.pmid: 23064873
references.citation: Development. 2003 May;130(10):2061-9
references.pmid: 12668621
references.citation: J Urol. 2013 Mar;189(3):884-90
references.pmid: 23009871
references.citation: N Engl J Med. 2012 Jan 12;366(2):141-9
references.pmid: 22236224
references.citation: Mol Cell Biol. 2001 Jan;21(1):224-34
references.pmid: 11113197
references.citation: Cancer Lett. 2013 Apr 28;330(2):217-24
references.pmid: 23219899
references.citation: Prostate. 2010 Dec 1;70(16):1729-38
references.pmid: 20564319
references.citation: Development. 1997 Dec;124(23):4781-91
references.pmid: 9428414
references.citation: Carcinogenesis. 2013 Jun;34(6):1260-4
references.pmid: 23393222
references.citation: J Natl Cancer Inst. 2012 Aug 22;104(16):1260-2
references.pmid: 22781434
references.citation: Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):675-80
references.pmid: 23396964
references.citation: JAMA. 2000 Apr 19;283(15):2008-12
references.pmid: 10789670
references.citation: Eur Urol. 2014 Jan;65(1):169-76
references.pmid: 22841674
references.citation: Prostate. 2013 Apr;73(5):542-8
references.pmid: 23334858
references.citation: Nat Genet. 2012 Dec;44(12):1326-9
references.pmid: 23104005
references.citation: BMJ. 2003 Sep 6;327(7414):557-60
references.pmid: 12958120